Why Is TRVN Stock Up 393.65% Yesterday?
$Trevena(TRVN.US$ stock is taking off on China drug approval news.
Partner Jiangsu Nhwa has received approval for Trevena’s OLINVYK.
Partner Jiangsu Nhwa has received approval for Trevena’s OLINVYK.
With this approval, Trevena will get a $3 million milestone payment from Jiangsu Nhwa. In addition to that milestone payment, Trevena could get another $15 million for the first commercial sale of OLINVYK in China.
What This Means for TRVN Stock
Investors in TRVN stock are set to benefit from the Chinese approval for OLINVYK. This will open the company up to a new source of revenue once sales commence in the country. That could result in a further boost to TRVN shares when the company next reports earnings.Chinese approval for OLINVYK. This will open the company up to a new source of revenue once sales commence in the country. That could result in a further boost to TRVN shares when the company next reports earnings.
Investors in TRVN stock are set to benefit from the Chinese approval for OLINVYK. This will open the company up to a new source of revenue once sales commence in the country. That could result in a further boost to TRVN shares when the company next reports earnings.Chinese approval for OLINVYK. This will open the company up to a new source of revenue once sales commence in the country. That could result in a further boost to TRVN shares when the company next reports earnings.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
